Traditional approaches to combatting COVID-19 typically focused on developing drugs that target exposed regions on the surface of the S protein that mediate ACE2 binding, and contemporary AI techniques often seek to replicate traditional drug-targeting approaches. The gene discussed is ACE2; the disease is COVID-19.